Kenneth Paul Shephard

Title: Kenneth Paul Shephard: Innovator in Pharmaceutical Chemistry

Introduction

Kenneth Paul Shephard is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Shephard has demonstrated his expertise and commitment to advancing medical science.

Latest Patents

Among his latest patents is the invention related to "Crystalline ceftiofur free acid." This patent focuses on a process for converting delta16-steroids to delta17(20)-20-silyl ethers. The process involves the reaction of preformed copper hydride or a metal hydride reducing agent in the presence of a copper species, along with a silylating agent. The resulting delta17(20)-20-silyl ethers serve as useful intermediates in the preparation of steroids that are beneficial as pharmaceuticals.

Career Highlights

Throughout his career, Kenneth Paul Shephard has worked with prominent companies in the pharmaceutical industry, including Pharmacia & Upjohn Company and The Upjohn Company. His work in these organizations has allowed him to contribute to significant advancements in drug development and pharmaceutical research.

Collaborations

Shephard has collaborated with notable colleagues, including Michael J. Dunn and Michael S. Bergren. These partnerships have further enriched his work and have led to innovative solutions in the field of pharmaceutical chemistry.

Conclusion

Kenneth Paul Shephard's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of important medical treatments.